SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001753926-21-000563
Filing Date
2021-10-12
Accepted
2021-10-12 11:10:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 F-1/A g082387_f1a.htm F-1/A 94289
2 EXHIBIT 10.13 g082387_ex10-13.htm EX-10.13 84605
  Complete submission text file 0001753926-21-000563.txt   179863
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-258741 | Film No.: 211317698
SIC: 2834 Pharmaceutical Preparations